16 Oct

Is Xarelto Potentially Linked to Increased Risk of Liver Injury?

Health Canada recently completed a safety review of Xarelto, an anti-coagulant medication manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. According to a Summary Safety Review, which was...

15 Oct

Ohio Parents Allege Zofran Caused Infant’s Death

October 15, San Diego, CA- Back in 1999, the FDA approved Zofran, a drug manufactured by GlaxoSmithKine, for use in cancer patients requiring chemotherapy or radiation therapy. While Zofran is used...

09 Oct

What the Makers of Xarelto Don’t Want You to Know

XARELTO - FDA LETTER WARNING OF OVERPROMOTION & MISBRANDING October 9, 2015 San Diego, CA – The FDA’s letter to the maker of Xarelto basically states that the company didn’t...

25 Sep

The Problem With Off-Label Drug Use

At your next trip to the doctor's office, consider this: The medication your doctor prescribed may not be approved for your specific condition or age group.  In the U.S., new...

15 Sep

Takeda to Move Forward with $2.3 Billion Actos Settlement

September 15th, 2015- A month ago, it seemed that Takeda might not get enough takers to move forward with its generous $2.3 billion offer to settle thousands of claims over...

10 Sep

FDA Revises Invokana Label to Include Bone Fracture Risk

September 10th, 2015- The FDA has strengthened the warning for the type 2 diabetes drug Invokana related to the increased risk of bone fractures and added new information about decreased bone...

01 Sep

Janssen Accused of Hiding Risperdal Autism Data

Janssen Pharmaceuticals, the manufacturer of Risperdal, which is widely used in autistic children, willingly withdrew data on its side effects from a 2003 study, according to evidence presented in a...

27 Aug

New Developments in Xarelto Side Effects Research

San Diego, CA -- August 27, 2015 Since it's introduction, Xarelto's run on the blood thinner market has been riddled with several lawsuits alleging that the drug causes serious side...

25 Aug

Sanofi and Bristol-Myers Catch Break in Plavix Case

San Diego, CA -- August 25, 2015 Unfortunately, Bristol-Myers Squibb and Sanofi scored a victory in a False Claims Act marketing case over their blood thinner, Plavix.  A federal judge...

17 Aug

Plaintiffs Apprehensive to Sign On For Actos Settlement

With a $2.37 billion settlement in April, Takeda, the maker of Actos, thought they were free of the thousands of lawsuits tied to cancer risks. Actos, the diabetes drug, is...

Categories

Recent post

What Our Clients Say